- Research Institute
- About Us
- Anesthesiology
- Cardiology
- Cardiothoracic Surgery
- Donation Information
- Endocrinology & General Medicine
- Gastroenterology
- Genetics/Genomics
- In-Patient Medicine
- Interventional Neuroradiology
- Neurology
- Northwest Community Clinical Oncology Program
- Oncology & Hematology
- Other Research Programs
- Research Institute Staff
- Surgery
Atrial Fibrillation
Title: CABANA - Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial
Purp ose: The study is being done to compare drug therapy and catheter ablation in patients with atrial fibrillation. This study will help decide which treatment approach is best or when one or the other therapy is preferred. The CABANA study will also compare the cost of care for the two treatment approaches and determine the effect these therapies have on quality of life.
Who Can Participate?
Diagnosis or Condition: Atrial fibrillation
Age: 18 yrs or older
Sex: Males and Females
Visits: Every 3 months during the first year; every 6 months thereafter
PI: Tariq Salam, MD
Study Coordinator: Meredith (Janey) Barnhart 253.403.7258
For more information, contact the Study Coordinator and reference Cabana study.
Dr. Tariq Salam Discusses Atrial Fibrillation